DelveInsight’s “Thyroid eye disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Thyroid eye disease, historical and forecasted epidemiology as well as the Thyroid eye disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Thyroid eye disease market report provides current treatment practices, emerging drugs, Thyroid eye disease market share of the individual therapies, current and forecasted Thyroid eye disease market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Thyroid eye disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Thyroid eye disease market.
Some of the key facts of the Thyroid eye disease Market Report:
Key benefits of the Thyroid eye disease Market report:
Got queries? Click here to know more about the Thyroid Eye Disease Market Landscape
Thyroid eye disease Overview
Thyroid eye disease (TED) is a complex orbital inflammatory disease, which can be sight-threatening, debilitating, and disfiguring. TED is also known as Graves ophthalmopathy, named after Robert J. Graves, an Irish physician who first described thyrotoxicosis in a woman presenting with goiter, rapid heartbeat, and exophthalmos.TED affects eye muscles, eyelids, tear glands and fatty tissues behind the eye to become inflamed. This can cause the eyes and eyelids to become red, swollen, and uncomfortable and the eyes can be pushed forward (‘staring’ or ‘bulging’ eyes).
Treatment of TED is based on the signs and symptoms displayed by the patient; there is no “one size fits all” approach. Generally, it is advisable to start with conservative measures, such as ocular lubrication with artificial tears, to manage symptoms of chronic irritation and redness. It is also imperative that the patient be advised to quit smoking because there is a clear link between smoking and disease activity. Medical treatment with systemic oral or pulsed intravenous corticosteroids should be reserved for patients with active inflammation resulting in increased orbital pressure, compressive optic neuropathy, severe periorbital edema, or similar presentations.
The key players are strengthening their market position through strategic mergers, agreements, and acquisitions which is expected to propel the growth of the thyroid eye disease treatment market over the forecasted period (2019-2032). For instance, in May 2017, Horizon Therapeutics acquired the River Vision Development Corp. and its pipeline drug teprotumumab, a human monoclonal antibody for the treatment of thyroid eye disease. This acquisition is expected to cater unmet needs for the treatment of thyroid eye disease.
Thyroid eye disease Epidemiological Insight
Thyroid eye disease Market Epidemiological Segmentation
Thyroid eye disease Market Outlook
The Thyroid eye disease market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Thyroid eye disease market trends by analyzing the impact of current Thyroid eye disease therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of Thyroid eye disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Thyroid eye disease market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Thyroid eye disease market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @Thyroid eye disease Market Landscape
Thyroid eye disease Key Companies
Thyroid eye disease Therapies
Table of Contents
Click here to read more about Thyroid eye disease Market
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/